Call us for quotes at (610) 458-1112 or 
Email us at primbiobiz@primbioresearch.com
PrimBio
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote

Primbio Breast CANCER Therapy Panel

Breast cancer is the most common cancer in women. 5-10% of breast cancers can be linked to gene mutations inherited from either parent.  The most common genes mutated in inherited breast cancer are BRCA1 and BRAC2.  However, 90% of breast cancers are the result of sporadic mutations in 29 other genes.   Next Generation Sequencing makes it possible to test all 31 genes across the entire exonic regions. Mutations in these genes provide important information regarding tumor development, tumor progression, and can be used as a reliable predictor of personalized cancer therapies.  We have developed a Breast Cancer Therapy Panel that includes the 31 genes associated with breast cancer and 38 genes that are related to drug sensitivity and efficacy.  This panel is designed to help doctors diagnose and provide treatment options for breast cancer patients and those at risk for breast cancer.
Molecular Diagnostic
​ Requisition Form
Hereditary Test
​Questionnaire
Sample Submission
​Guidelines
© COPYRIGHT 2016. ALL RIGHTS RESERVED.